In the Media

Wall Street Journal reporter Jo Craven McGinty writes that a study co-authored by MIT researchers finds the surge in new drug approvals typically seen every December leads to an increase in hospitalizations, life-threatening events and deaths. McGinty notes that the researchers concluded, “drugs approved during end-of-month or end-of-year surges should receive additional scrutiny.”